Empagliflozin prevention of heart failure development in diabetes is associated with an improvement in cardiac energy producition

26 August 2018 (10:05 - 10:55)
Organised by:
Congress Presentation Part of: Targeting reverse remodelling in heart failure Pharmacotherapy ESC Premium Access ESC Congress 2018
You may be interested in
thumbnail
Congress Presentation
3 September 2019